News & Updates
Filter by Specialty:
Show Multimedia Only

Esketamine monotherapy shows robust, rapid efficacy as treatment for TRD
a day ago
byMike Ng
Intranasal esketamine, administered at two fixed doses as monotherapy for treatment-resistant depression (TRD), has demonstrated robust and rapid efficacy in a phase IV double-blind, placebo-controlled randomized trial.
Esketamine monotherapy shows robust, rapid efficacy as treatment for TRD
a day ago
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
byMike Ng
A 12-month therapeutic intervention with self-administered abatacept can delay the onset of rheumatoid arthritis (RA) in at-risk individuals for up to 4 years, according to results from the ALTO follow-up study presented at EULAR 2025.
RA onset delayed through 4 years with 1-year abatacept treatment in at-risk individuals
16 Jul 2025
Exercise prevents death in diabetes patients with MI
15 Jul 2025
byStephen Padilla
Regularly engaging in any physical activity (PA) can help reduce the risk of death in patients with diabetes and myocardial infarction (MI), suggests a study presented at ADA 2025.